|
Market Closed -
Nasdaq
23:00:00 14/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 73.02 USD | -3.82% |
|
-4.52% | +72.71% |
| 08-14 | Nektar Therapeutics, Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Nektar Therapeutics Q2 Loss Narrows, Revenue Declines | MT |
| Market Cap | 2.49B 2.15B 2.02B 1.84B 3.46B 238B 3.52B 23.71B 9.27B 119B 9.36B 9.16B 397B | P/E 2026 * |
-8.83x | P/E 2027 * | -6.98x |
|---|---|---|---|---|---|
| Enterprise Value | 2.49B 2.15B 2.02B 1.84B 3.46B 238B 3.52B 23.71B 9.27B 119B 9.36B 9.16B 397B | EV / Sales 2026 * |
59.2x | EV / Sales 2027 * | 42.5x |
| Free-Float |
99.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nektar Therapeutics
| 1 day | -3.82% | ||
| 1 week | -4.52% | ||
| Current month | +3.33% | ||
| 1 month | +6.91% | ||
| 3 months | +3.40% | ||
| 6 months | +2.37% | ||
| Current year | +72.71% |
| 1 week | 72.05 |  | 77.22 |
| 1 month | 64.24 | | 77.22 |
| Current year | 33.4 | | 109 |
| 1 year | 25.34 | | 109 |
| 3 years | 6.19 | | 109 |
| 5 years | 6.19 | | 290.55 |
| 10 years | 6.19 | | 1,670.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 73 | 01/01/2007 |
Linda Rubinstein
DFI | Director of Finance/CFO | 60 | 15/05/2026 |
| Chief Tech/Sci/R&D Officer | 52 | 01/07/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Roy Whitfield
BRD | Director/Board Member | 72 | 01/08/2000 |
Robert Chess
CHM | Chairman | 69 | 01/05/1992 |
Howard Robin
BRD | Director/Board Member | 73 | 01/02/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/24/26 A | Free | Chief Technology Officer | 16,500 | 0.0488% | ||
| 7/24/26 A | Free | Chief Executive Officer | 57,200 | 0.1693% | ||
| 6/30/26 A | Sell | Chief Technology Officer | -5,681 | 0.0168% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.82% | -4.52% | +167.87% | +501.51% | 2.49B | |
| -1.90% | +2.85% | +62.82% | +104.13% | 70.07B | |
| -3.21% | -4.32% | +31.85% | +57.27% | 52.87B | |
| -2.05% | -5.61% | -3.18% | +449.71% | 27.02B | |
| -1.27% | -1.57% | +45.90% | +8.25% | 23.61B | |
| +1.05% | -0.62% | -18.00% | -11.93% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +531.28% | 19.43B | |
| +0.10% | +1.40% | +35.36% | -19.94% | 18.75B | |
| -0.95% | -3.52% | +19.93% | +594.00% | 15.85B | |
| +1.24% | -5.23% | +33.75% | +137.66% | 12.7B | |
| Average | -0.70% | +1.30% | +64.27% | +235.19% | 26.62B | |
| Weighted average by Cap. | -1.11% | +0.51% | +51.33% | +168.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.13M 36.38M 34.19M 31.09M 58.46M 4.03B 59.42M 401M 157M 2.02B 158M 155M 6.7B | 58.65M 50.66M 47.6M 43.29M 81.39M 5.61B 82.73M 558M 218M 2.81B 220M 215M 9.33B |
| Net income | -251M -216M -203M -185M -348M -23.97B -354M -2.38B -932M -12B -941M -921M -39.89B | -365M -315M -296M -269M -506M -34.87B -514M -3.47B -1.36B -17.46B -1.37B -1.34B -58.03B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | $73.02 | -3.82% | 828,396 |
| 13/08/26 | $75.92 | -0.14% | 628,205 |
| 12/08/26 | $76.03 | +0.70% | 542,900 |
| 11/08/26 | $75.50 | +0.85% | 325,859 |
| 10/08/26 | $74.86 | -2.12% | 486,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NKTR Stock
Select your edition
All financial news and data tailored to specific country editions
